Literature DB >> 15728928

Antimicrobial susceptibility of Shigella sonnei isolates in Japan and molecular analysis of S. sonnei isolates with reduced susceptibility to fluoroquinolones.

Kenji Hirose1, Jun Terajima, Hidemasa Izumiya, Kazumichi Tamura, Eiji Arakawa, Nobuko Takai, Haruo Watanabe.   

Abstract

We performed susceptibility testing with Shigella sonnei isolates from imported and domestic cases of infection in Japan during 2001 and 2002. Some S. sonnei isolates were resistant to nalidixic acid, tetracycline, and trimethoprim-sulfamethoxazole. Most of the nalidixic acid-resistant strains showed reduced susceptibility to fluoroquinolones but did not show fluoroquinolone resistance.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15728928      PMCID： PMC549262          DOI： 10.1128/AAC.49.3.1203-1205.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  10 in total

1.  Detection of decreased in vitro susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A.

Authors:  E J Threlfall; J A Skinner; L R Ward
Journal:  J Antimicrob Chemother       Date:  2001-11       Impact factor: 5.790

2.  Multidrug-resistant Shigella dysenteriae type 1 in south Asia.

Authors:  S K Bhattacharya; K Sarkar; G Balakrish Nair; A S G Faruque; David A Sack
Journal:  Lancet Infect Dis       Date:  2003-12       Impact factor: 25.071

3.  Retrospective analysis of the first clonal outbreak of nalidixic acid-resistant Shigella sonnei shigellosis in Israel.

Authors:  D Dagan; N Orr; M Yavzori; Y Yuhas; D Meron; S Ashkenazi; D Cohen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-12-10       Impact factor: 3.267

4.  Is it time to change fluoroquinolone breakpoints for Salmonella spp.?

Authors:  Frank Møller Aarestrup; Camilla Wiuff; Kåre Mølbak; E John Threlfall
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

5.  Fluoroquinolone-resistant Shigella dysenteriae type 1 in northeastern Bangladesh.

Authors:  A Naheed; P Kalluri; K A Talukder; A S G Faruque; F Khatun; G B Nair; E D Mintz; R F Breiman
Journal:  Lancet Infect Dis       Date:  2004-10       Impact factor: 25.071

6.  Novel combination of mutations in the DNA gyrase and topoisomerase IV genes in laboratory-grown fluoroquinolone-resistant Shigella flexneri mutants.

Authors:  Y W Chu; E T Houang; A F Cheng
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

7.  Antibiotic susceptibilities of Salmonella enterica serovar Typhi and S. enterica serovar Paratyphi A isolated from patients in Japan.

Authors:  K Hirose; K Tamura; H Sagara; H Watanabe
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

8.  Antimicrobial resistance in Shigella flexneri and Shigella sonnei in Hong Kong, 1986 to 1995.

Authors:  Y W Chu; E T Houang; D J Lyon; J M Ling; T K Ng; A F Cheng
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

9.  Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.

Authors:  K L Kotloff; J P Winickoff; B Ivanoff; J D Clemens; D L Swerdlow; P J Sansonetti; G K Adak; M M Levine
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

10.  DNA sequence analysis of DNA gyrase and DNA topoisomerase IV quinolone resistance-determining regions of Salmonella enterica serovar Typhi and serovar Paratyphi A.

Authors:  Kenji Hirose; Ai Hashimoto; Kazumichi Tamura; Yoshiaki Kawamura; Takayuki Ezaki; Hiroko Sagara; Haruo Watanabe
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191
  10 in total
  16 in total

1.  High genetic stability of integrons in clinical isolates of Shigella spp. of worldwide origin.

Authors:  Véronique Dubois; Marie-Pierre Parizano; Corinne Arpin; Laure Coulange; Marie-Christine Bezian; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2007-01-22       Impact factor: 5.191

2.  High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002.

Authors:  Sumathi Sivapalasingam; Jennifer M Nelson; Kevin Joyce; Mike Hoekstra; Frederick J Angulo; Eric D Mintz
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

3.  Emerging resistance to newer antimicrobial agents among Shigella isolated from Finnish foreign travellers.

Authors:  K Haukka; A Siitonen
Journal:  Epidemiol Infect       Date:  2007-06-20       Impact factor: 2.451

4.  Options for treating resistant Shigella species infections in children.

Authors:  Sharon M Erdman; Elizabeth E Buckner; Janet F Hindler
Journal:  J Pediatr Pharmacol Ther       Date:  2008-01

5.  Genomic and proteomic characterization of two strains of Shigella flexneri 2 isolated from infants' stool samples in Argentina.

Authors:  Mónica F Torrez Lamberti; Lucrecia C Terán; Fabián E Lopez; María de Las Mercedes Pescaretti; Mónica A Delgado
Journal:  BMC Genomics       Date:  2022-07-08       Impact factor: 4.547

6.  Distribution of serogroups and serotypes of multiple drug resistant Shigella isolates.

Authors:  Ja Opintan; Mercy J Newman
Journal:  Ghana Med J       Date:  2007-03

7.  First report of the qnrA determinant in Shigella sonnei isolated from China.

Authors:  H M Qian; T T Qin; G Y Liu; J Li; P Ma; X X Kong; B Gu; C J Bao
Journal:  Epidemiol Infect       Date:  2017-05-24       Impact factor: 4.434

8.  Changing patterns and widening of antibiotic resistance in Shigella spp. over a decade (2000-2011), Andaman Islands, India.

Authors:  D Bhattacharya; H Bhattacharya; D S Sayi; A P Bharadwaj; M Singhania; A P Sugunan; S Roy
Journal:  Epidemiol Infect       Date:  2014-04-24       Impact factor: 4.434

9.  Antimicrobial resistance in Shigella--rapid increase & widening of spectrum in Andaman Islands, India.

Authors:  Debdutta Bhattacharya; A P Sugunan; Haimanti Bhattacharjee; R Thamizhmani; D S Sayi; K Thanasekaran; Sathya Prakash Manimunda; A R Ghosh; A P Bharadwaj; M Singhania; Subarna Roy
Journal:  Indian J Med Res       Date:  2012-03       Impact factor: 2.375

10.  Prevalence and trends of aminoglycoside resistance in Shigella worldwide, 1999-2010.

Authors:  Bing Gu; Xing Ke; Shiyang Pan; Yan Cao; Ling Zhuang; Rongbin Yu; Huimin Qian; Genyan Liu; Mingqing Tong
Journal:  J Biomed Res       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.